بواسیزامب: نوسخهلر آراسینداکی فرق
محتوای حذفشده محتوای افزودهشده
4321bot (دانیشیق | چالیشمالار) ک دواء لار using AWB |
4321bot (دانیشیق | چالیشمالار) Automated import of articles - append on top |
||
خط ۱:
{{Infobox drug
<!-- Monoclonal antibody data -->
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 477165031
| type = mab
| mab_type = mab
| source = zu/o
| target = [[vascular endothelial growth factor A|VEGF-A]]
<!-- Clinical data -->
| pronounce = {{IPAc-en|b|ɛ|v|ə|ˈ|s|ɪ|zj|uː|m|æ|b}}<ref name="NIHp">{{cite web| title=Bevacizumab Injection: MedlinePlus Drug Information| url= http://www.nlm.nih.gov/medlineplus/druginfo/meds/a607001.html| agency=NLM.nih.gov | date=28 February 2014 }}</ref>
| tradename = Avastin, other<ref>{{cite web|title=Bevacizumab - Drugs.com|url=https://www.drugs.com/international/bevacizumab.html|website=www.drugs.com|accessdate=28 December 2016}}</ref>
| Drugs.com = {{Drugs.com|monograph|bevacizumab}}
| licence_EU = yes
| licence_US = Bevacizumab
| pregnancy_US = C
| legal_status = Rx-only
| routes_of_administration = [[تزریق وریدی]]
<!-- Pharmacokinetic data -->
| bioavailability = 100% (IV only)
| elimination_half-life = 20 days (range: 11–50 days)
<!-- Identifiers -->
| CAS_number_Ref = {{Cascite|correct|??}}
| CAS_number = 216974-75-3
| ATC_prefix = L01
| ATC_suffix = XC07
| DrugBank_Ref = {{Drugbankcite|correct|drugbank}}
| DrugBank = DB00112
| UNII_Ref = {{Fdacite|correct|FDA}}
| UNII = 2S9ZZM9Q9V
| KEGG_Ref = {{Keggcite|correct|kegg}}
| KEGG = D06409
| ChEMBL_Ref = {{Ebicite|changed|EBI}}
| ChEMBL = 1201583
| ChemSpiderID_Ref = {{Chemspidercite|changed|chemspider}}
| ChemSpiderID = none
<!-- Chemical data -->
| C=6638 | H=10160 | N=1720 | O=2108 | S=44
| molecular_weight = 149,196.82 g/mol
}}
'''بواسیزامب''' ({{Lang-en|Bevacizumab}}, {{Lang-zh|安维汀}}، {{Lang-ar|بيفاسيزوماب}}، {{Lang-ru|Бевацизумаб}}) بیر [[بیلشیک|شیمیایی بیلشیک]] [[دواء]]. بواسیزامب [[سرطان]] اۆچون ایستیفاده اوْلونور.
== بیرده باخ ==
| |||